Head & Neck Cancers | Specialty

October 2011: Trials in Progress

October 21st 2011

This month's collection of trials in progress highlights trials presented at the 2011 American Society of Clinical Meeting.

Dr. Burtness on the Head and Neck Symposium Design

September 28th 2011

Dr. Barbara Burtness from Fox Chase Cancer Center on the Head and Neck Symposium Design

Dr. Burtness on the Head and Neck Cancer Symposium

September 27th 2011

Dr. Barbara Burtness from Fox Chase Cancer Center Discusses the Upcoming Head and Neck Cancer Symposium

Panitumumab Extends Progression-Free Survival in HPV-Negative Subset of Advanced Head and Neck Cancer

September 25th 2011

Panitumumab + chemo improves OS and PFS in patients with metastatic carcinoma of the head and neck that were negative for HPV.

Conference Corner: 2 Upcoming Physicians' Education Resource Conferences

August 31st 2011

The 2 upcoming conferences include the 7th Annual Multidisciplinary Symposium on Head and Neck Cancer and the School of Breast Oncology.

ASCO Highlights: Trials in Progress

August 23rd 2011

The following is a roundup of TPS abstracts that feature trials open to patients aged >17 years with a broad range of cancer types.

Study Shows No Survival Benefit of Cetuximab Over Cisplatin-Based Chemoradiation in Head and Neck Cancers

August 4th 2011

Patients with locally advanced head and neck cancer gained no survival benefit with the addition of cetuximab to chemoradiation.

Novel Therapeutics Target Gene Mutations, Tumor Suppressors

August 2nd 2011

Previously unknown genetic methylation patterns and new mutations for squamous cell carcinoma of the head and neck discovered.

Dr. Vogelzang Discusses Cabozantinib's Dose Size

June 29th 2011

Dr. NJ Vogelzang from the Comprehensive Cancer Centers of Nevada Discusses Cabozantinib's Dose Size

Dr. Vogelzang Describes Cabozantinib's Side Effects

June 21st 2011

Dr. Nicholas Vogelzang from the Comprehensive Cancer Centers of Nevada Describes Cabozantinib's side effects

Hedgehog Pathway Inhibitor GDC-0449 Reduces Lesion Size in Patients With Basal Cell Carcinoma

June 20th 2011

Patients with basal cell carcinoma had an eightfold decrease in lesion area when treated with GDC-0449

Socioeconomic Status Bears Little Impact on Survival Rates

June 10th 2011

Primary cancers of the lung, esophagus, and pancreas-all of which have a poor prognosis-account for >35% of all cancer deaths in the United States annually

NCCN's 16th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care

May 24th 2011

Each year the National Comprehensive Cancer Network (NCCN) presents the latest updates to its Clinical Practice Guidelines in Oncology, as well as the latest cancer therapies by key opinion leaders.

Osteosarcoma Survivor Sings Message of Hope

May 9th 2011

Singer and songwriter Charlie Lustman has become an inspirational voice for the over 12 million cancer survivors living in the United States

FDA Approves Vandetanib for Metastatic Medullary Thyroid Cancer

April 7th 2011

The FDA has approved vandetanib for the treatment of unresectable, late-stage, metastatic medullary thyroid cancer

Dr. Langmuir Explains the Side Effects of Vandetanib

April 7th 2011

Childhood Radiation Exposure Risks Linger Beyond 50 Years

March 28th 2011

It has been more than half a century since radiation treatment was mistakenly deemed necessary to help infants with enlarged thymus glands avoid the risk of status lymphaticus and suffocation

Injection Laryngoplasty Is Effective for Laryngeal Dysfunction in Cancer Patients

March 25th 2011

New data suggest that office-based injection laryngoplasty (IL) appears to be a safe and effective treatment for laryngeal dysfunction in cancer patients.

Prereferral Treatment of Head and Neck Cancer Patients Disregards Guidelines

March 16th 2011

New findings indicate that prereferral care does not conform to clinical practice guidelines in nearly half of patients with head and neck cancer who are referred to a tertiary care center with persistent or recurrent disease, new findings indicate.

Net Guides: Head and Neck Cancers

March 15th 2011

Useful Online Resources and Clinical Trials for Head and Neck Cancers